» Articles » PMID: 29254461

Impact of Lesion Morphology on Durability After Angioplasty of Failed Arteriovenous Fistulas in Hemodialysis Patients

Overview
Journal J Endovasc Ther
Publisher Sage Publications
Date 2017 Dec 20
PMID 29254461
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To investigate if morphological patterns of arteriovenous fistula (AVF) venous lesions affect primary patency after percutaneous transluminal angioplasty (PTA).

Methods: From July 2014 to June 2015, 262 patients underwent PTA for failed AVFs. A total of 104 patients were excluded owing to (1) calcification or AVF occlusion precluding ultrasound examination, (2) central venous or arterial lesions, and (3) no follow-up, leaving 158 patients (mean age 71±12; 96 men) for analysis. More than half of the patients had one or more previous PTAs for the failed AVF. Prior to PTA the stenotic lesions were assessed using ultrasonography to determine stenotic patterns at the minimum lumen area site and to evaluate the flow volume in the brachial artery. Three stenotic patterns were identified: intimal hyperplasia (IH) stenosis (n=110), shrinking lumen stenosis (n=32), and venous valve-related stenosis (n=16). The main outcome measure was primary patency after PTA estimated using Kaplan-Meier analysis. Predictors for loss of primary patency were determined using a multivariate Cox proportional hazards model; the results are presented as the adjusted hazard ratio (HR) and 95% confidence interval (CI).

Results: Median follow-up after PTA was 6.3 months (interquartile range 3.3, 10.5). The 6-month primary patency estimates were 56%±5% in the IH group, 40±9% in the shrinking lumen group, and 100% in the valve stenosis group (IH vs shrinking, p=0.013; IH vs valve, p=0.003). In multivariate analysis, shrinking lumen morphology had a negative impact on primary patency (HR 2.05, 95% CI 1.25 to 3.36, p=0.005), while venous valve-related stenosis had a positive impact (HR 0.19, 95% CI 0.04 to 0.79, p=0.023). Flow volume (10-mL/min increments; HR 0.97, 95% CI 0.96 to 0.99, p=0.004) and history of PTA (HR 1.66, 95% CI 1.06 to 2.60, p=0.029) were also independently associated with primary patency after PTA.

Conclusion: The patterns of AVF stenosis as determined by ultrasound can affect the outcome of treatment with balloon dilation.

Citing Articles

Long-Term Efficacy of Ultrasound-Guided Percutaneous Transluminal Angioplasty for Arteriovenous Fistula Outflow Stenosis Caused by Venous Valve.

Chen B, Chen L, Yang Q, Gao X, Lai Q, Tu B Kidney Dis (Basel). 2024; 10(2):89-96.

PMID: 38751797 PMC: 11095604. DOI: 10.1159/000536309.


Comparison of ultrasound features and lesion sites in dysfunctional arteriovenous fistula.

Wang Y, Huang X, Zhang Y, Li J, Li J, Ye Z Ren Fail. 2024; 46(1):2294148.

PMID: 38186351 PMC: 10776081. DOI: 10.1080/0886022X.2023.2294148.


Factors affecting arteriovenous access patency after percutaneous transluminal angioplasty in chronic haemodialysis patients under vascular access monitoring and surveillance: a single-centre observational study.

Wu C, Tarng D, Yang C, Leu J, Lin C BMJ Open. 2022; 12(1):e055763.

PMID: 35074822 PMC: 8788314. DOI: 10.1136/bmjopen-2021-055763.


Morphological Lesion Types Are Associated with Primary and Secondary Patency Rates after High-Pressure Balloon Angioplasty for Dysfunctional Arteriovenous Fistulas.

Chen L, Zhang W, Tan J, Hu M, Shi W, Zhang M Blood Purif. 2021; 51(5):425-434.

PMID: 34320498 PMC: 9153343. DOI: 10.1159/000516883.


Predictors associated with early and late restenosis of arteriovenous fistulas and grafts after percutaneous transluminal angiography.

Zheng Q, Xie B, Xie X, Zhang W, Hou J, Feng Z Ann Transl Med. 2021; 9(2):132.

PMID: 33569434 PMC: 7867940. DOI: 10.21037/atm-20-7690.